ORBIMED ADVISORS LLC 13D and 13G filings for Xtant Medical Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-14 7:09 pm Sale |
2025-04-10 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 0 0.000% |
-73,114,592 (Position Closed) |
Filing |
| 2024-09-10 4:12 pm Unchanged |
2024-09-03 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 73,114,592 52.700% |
0 (Unchanged) |
Filing |
| 2023-08-03 4:59 pm Unchanged |
2023-08-01 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 73,114,592 56.700% |
0 (Unchanged) |
Filing |
| 2023-05-05 11:14 am Unchanged |
2023-05-01 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 73,114,592 67.100% |
0 (Unchanged) |
Filing |
| 2022-08-30 4:37 pm Purchase |
2022-08-26 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 73,114,592 67.900% |
241,098 (+0.33%) |
Filing |
| 2021-04-09 4:36 pm Purchase |
2021-04-06 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 72,873,494 84.000% |
70,422 (+0.10%) |
Filing |
| 2021-02-25 7:41 pm Sale |
2021-02-24 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 72,803,072 93.600% |
-7,309 (-0.01%) |
Filing |
| 2020-10-05 5:27 pm Purchase |
2020-10-01 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 72,810,381 94.800% |
58,796,060 (+419.54%) |
Filing |
| 2020-05-20 4:54 pm Purchase |
2020-05-06 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 14,014,321 77.700% |
2,400,000 (+20.66%) |
Filing |